A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: considerations. Tang Y, Chen Y, Chen HN. J Hepatol 2022 Jun 8. pii: S0168-8278(22)00354.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tang Y, Chen Y, Chen HN. A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: considerations. J Hepatol 2022 Jun 8. pii: S0168-8278(22)00354.
PMID: 35690263